These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 21810423)

  • 1. Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts.
    Warejcka DJ; Narayan M; Twining SS
    Exp Eye Res; 2011 Nov; 93(5):618-27. PubMed ID: 21810423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
    McGowen R; Biliran H; Sager R; Sheng S
    Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
    Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of uPA, uPAR, PAI-1, and maspin in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Sep; 36(8):488-94. PubMed ID: 17686008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts.
    Horswill MA; Narayan M; Warejcka DJ; Cirillo LA; Twining SS
    Exp Eye Res; 2008 Apr; 86(4):586-600. PubMed ID: 18291368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
    Zhang X; Chaudhry A; Chintala SK
    Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
    Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
    Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory Mechanism of Collagen Degradation by Keratocytes and Corneal Inflammation: The Role of Urokinase-Type Plasminogen Activator.
    Sugioka K; Mishima H; Kodama A; Itahashi M; Fukuda M; Shimomura Y
    Cornea; 2016 Nov; 35 Suppl 1():S59-S64. PubMed ID: 27661072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maspin inhibits cell migration in the absence of protease inhibitory activity.
    Bass R; Fernández AM; Ellis V
    J Biol Chem; 2002 Dec; 277(49):46845-8. PubMed ID: 12384513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
    J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.
    Hu ZY; Liu YX; Liu K; Byrne S; Ny T; Feng Q; Ockleford CD
    J Anat; 1999 Feb; 194 ( Pt 2)(Pt 2):183-95. PubMed ID: 10337950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maspin: synthesis by human cornea and regulation of in vitro stromal cell adhesion to extracellular matrix.
    Ngamkitidechakul C; Burke JM; O'Brien WJ; Twining SS
    Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3135-41. PubMed ID: 11726614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin alters the synthesis and processing of CYR61/CCN1 in human corneal stromal fibroblasts and myofibroblasts through multiple distinct mechanisms.
    Andreae EA; Warejcka DJ; Twining SS
    Mol Vis; 2020; 26():540-562. PubMed ID: 32818017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.
    Biliran H; Sheng S
    Cancer Res; 2001 Dec; 61(24):8676-82. PubMed ID: 11751384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. uPA binding to PAI-1 induces corneal myofibroblast differentiation on vitronectin.
    Wang L; Ly CM; Ko CY; Meyers EE; Lawrence DA; Bernstein AM
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4765-75. PubMed ID: 22700714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
    Bator JM; Cohen RL; Chambers DA
    Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential conversion of plasminogen to angiostatin by human corneal cell populations.
    Warejcka DJ; Vaughan KA; Bernstein AM; Twining SS
    Mol Vis; 2005 Oct; 11():859-68. PubMed ID: 16270025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.
    Reinartz J; Schaefer B; Bechtel MJ; Kramer MD
    Exp Cell Res; 1996 Feb; 223(1):91-101. PubMed ID: 8635500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.
    Behrendt N; List K; Andreasen PA; Danø K
    Biochem J; 2003 Apr; 371(Pt 2):277-87. PubMed ID: 12534347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.